These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2282682)
1. [Nursing care of leukemia patients in cytolysis syndrome by chemotherapy]. Liu K Zhonghua Hu Li Za Zhi; 1990 Dec; 25(12):625-6. PubMed ID: 2282682 [No Abstract] [Full Text] [Related]
3. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia]. Paśnicki M Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239 [No Abstract] [Full Text] [Related]
4. Acute myeloid leukemia in adults: experience at AIIMS. Raina V; Kochupillai V J Assoc Physicians India; 1983 Aug; 31(8):511-4. PubMed ID: 6581155 [No Abstract] [Full Text] [Related]
5. Intensive therapy for adult acute lymphoblastic leukemia: preliminary results of the idarubicin/vincristine/L-asparaginase/prednisolone regimen. Bassan R; Battista R; Viero P; Pogliani E; Rossi G; Lambertenghi-Deliliers G; Rambaldi A; D'Emilio A; Buelli M; Borleri G Semin Oncol; 1993 Dec; 20(6 Suppl 8):39-46. PubMed ID: 7507263 [TBL] [Abstract][Full Text] [Related]
6. [Therapeutic effects of chemotherapeutic regimen with pirarubicin for adult high-risk acute leukemia]. Huang F; Meng FY; Xue B; Liu XL; Zhang Y; Ye CX; Zhang X Di Yi Jun Yi Da Xue Xue Bao; 2004 Jul; 24(7):768-70. PubMed ID: 15257898 [TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy of relapsed AML and ALL]. Nishikawa K Rinsho Ketsueki; 1996 Aug; 37(8):647-50. PubMed ID: 8827871 [No Abstract] [Full Text] [Related]
8. [Possibilities for the cure of acute myeloblastic leukemia with the modified VAPA regimen: preliminary results]. Díaz Mediavilla J; del Potro Gómez E; Llorente Pérez L; Martínez Martínez R; Guerra Moyano JL; de la Vega Bueno E; Alvarez Carmona A; Krsnik Castelló I; Alarcón Zurita C; Rodríguez Vázquez M Med Clin (Barc); 1984 Dec; 83(19):783-6. PubMed ID: 6597329 [No Abstract] [Full Text] [Related]
9. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia]. Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381 [TBL] [Abstract][Full Text] [Related]
11. Plasma ammonia in patients with acute leukemia. Xu SR; Yao EG; Dong ZR; Liu RS; Pan L; Lin FR; Zhang RX; Liu MC; Ma BB; Yin JQ Chin Med J (Engl); 1992 Sep; 105(9):713-6. PubMed ID: 1288971 [TBL] [Abstract][Full Text] [Related]
12. [Acute lymphoblastic leukemia complicated with tumor lysis syndrome--four cases report]. He H; Li C; Han M Zhonghua Xue Ye Xue Za Zhi; 1999 Jun; 20(6):310-2. PubMed ID: 11721390 [TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus and pancreatitis as a complication of L-asparaginase therapy. Charan VD; Desai N; Singh AP; Choudhry VP Indian Pediatr; 1993 Jun; 30(6):809-10. PubMed ID: 8132268 [No Abstract] [Full Text] [Related]
14. [Hyperphosphatemia and transient renal insufficiency following chemotherapy of acute lymphoblastic leukemia]. Aubert JD; Claeys M; Zwahlen A; Wauters JP Schweiz Med Wochenschr; 1988 Dec; 118(51):1953-6. PubMed ID: 3212426 [TBL] [Abstract][Full Text] [Related]
15. [Pilot late phase II study of KRN8602 (MX2), a novel anthracycline derivative, for acute leukemia--a dose finding study in combination]. Hiraoka A; Sampi K; Kuraishi Y; Takemoto Y; Okabe K; Tamura K; Ogawa M Gan To Kagaku Ryoho; 1999 Jan; 26(1):93-9. PubMed ID: 9987504 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic paracentesis in an acute lymphoblastic leukemia child without characteristic symptoms of pancreatitis. Chao YH; Sheu JN; Chen SM; Wu KH J Pediatr Hematol Oncol; 2013 Jan; 35(1):e47. PubMed ID: 22858569 [No Abstract] [Full Text] [Related]
18. Electrocardiographic case--electrocardiographic clinical diagnosis in a patient with post-chemotherapy emesis and oliguria. Fadilah SS Singapore Med J; 1999 Aug; 40(8):553-5. PubMed ID: 10572501 [No Abstract] [Full Text] [Related]
19. Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study. Bassan R; Pogliani E; Lerede T; Fabris P; Rossi G; Morandi S; Casula P; Lambertenghi-Deliliers G; Vespignani M; Izzi T; Coser P; Corneo G; Barbui T Haematologica; 1999 Dec; 84(12):1088-93. PubMed ID: 10586210 [TBL] [Abstract][Full Text] [Related]
20. [A study on apoptotic cell death during chemotherapy of patients with acute leukemia]. Ren X; Gao H; Wang S Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):191-2. PubMed ID: 10921004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]